Abstract
Since ultrasound (US) has been widely used in clinical routine diagnostic of the liver and abdomen, it is easy to demonstrate a livertumor in an early and presymptomatic stage. Indications for US examination could be thorough basic diagnostic routinely done as screening or in connection with other, mostly malign diseases and abdominal pain of unknown origin. It is necessary to make an in-vivo differential diagnosis, since the different types of liver tumors have a different prognosis and therefore none, less or more therapeutic interventions are indicated enhancing the possibility and extent of complications.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Altmann H (1983) ‘Neubildungen der Leber: Pathologie and Pathogenese.’ In: Häring R (ed), Chirurgie der Leber, edition medizin, Weinheim-Deerfield, Beach-Basel.
Schmidt G, Borsch G, Wegner M (1985) ‘Benigne Lebertumoren: Diagnostische and therapeutische Aspekte.’ Internistische Welt 7/27: 196–200.
Clements D, Hubscher S, West R, Elias E, McMaster P (1986) ‘Epitheloid Haemangioendothelioma. J. Hepatology 2: 441–449.
Dunham L, Bailar J (1968) ‘World maps of cancer mortality rates and frequency rates.’ J Natn Cancer Inst 42: 155.
Nelson RC, Chezmar JL (1990) ‘Diagnostic approach to hepatic hemangiomas.’ Radiology 176: 11–13.
Trastek V, van Heerden JA, Sheedy II PF, Adson MA (1983) ‘Cavernous hemangiomas of the liver. Resect or observe?’ A J Surg 145: 49–53.
Walt A (1977) ‘Cysts and benign tumors of the liver.’ Surg Clin North Am 57: 449.
Neuhaus P, Brölsch C, Ringe B, Gratz K, Majewski A, Pichlmayr R (1984) ‘Diagnostik and Therapie von Lebertumoren.’ Therapiewoche 34: 4018–4032.
Marchal G, Baert A, Fevery J, Klint E, Peeters S, van Dijck X, deMaeyer P, Usewils R, Wilms G (1983) ‘Ultrasonography of liver hemangioma.’ Fortschr Röntgenstr 138: 201.
Demangeat J-L, Manil L, Demangeat C, Rico E, Staedel-Flaig C, Duclos B, Brunot B, Jaeck D, Bellet D, Constantinesco A (1988) ‘Is anti-alphafetoprotein immunoscintigraphy a promising approach for the diagnosis of hepatoma?’ Eur J Nucl Med 14: 612–620.
Order S, Klein J, Leichner P, Frincke J, Lollo C, Carlo D (1985) ‘90Yttrium antiferritin - a new therapeutic radiolabeled antibody.’ Int J Radiation Oncology Biol Phys 12: 277–281.
Hahn P, Stark D, Weissleder R, Elizondo G, Saini S, Ferrucci J (1990) ‘Clinical application of superparamagnetic iron oxide to MR imaging of tissue perfusion in vascular liver tumors.’ Radiology 174: 361–366.
Semmler W, Bachert-Baumann P, Gückel F, Ermark F, Schlag P, Lorenz W, van Kaick G (1990) ‘Real-time follow-up of 5-fluorouracil metabolism in the liver of tumor patients by means of F-19 MR spectroscopy.’ Radiology 174: 141–145.
Strauss LG, Clorius JH, Lehner B (1988) ‘F-18-uracil accumulation in liver metastases after i.v. and i.a. tracer injection.’ J Nucl Med 29 (suppl.): 776.
Lubin E, Zevitus Z (1972) ‘Blood pool scanning in investigating hepatic mass lesions.’ Sem Nucl Med 2: 128.
Engel M, Marks D, Sandler M, Shetty P (1983) ‘Differentiation of focal intrahepatic lesions with 99mTc-red blood cell imaging.’ Radiology 146: 517.
Front D, Israel O, Groshar D, Weiniger J (1984) ‘99mTc-labeled red blood cell imaging.’ Sem Nucl Med 12/3: 226.
Biersack H, Thelen M, Torres J, Lackner K, Winkler C (1980) ‘Focal nodular hyperplasia of the liver as established by 99mTc-sulfur colloid and HIDA scintigraphy.’ Radiology 137: 187.
Harvey E, Loberg M, Cooper M (1975) ‘A new radiopharmaceutical for hepatobiliary imaging.’ J Nucl Med 16: 533.
Creutzig H, Gratz K, Müller S, Schober O, Brölsch C, Neuhaus, P, Lang W (1984) ‘Classification of liver tumors by radionuclide imaging.’ J Nucl Med 25: 402.
Rabinowitz S, McKusick K, Strauss HW, (1984) ‘99mTc red blood cell scintigraphy in evaluating focal liver lesions.’ AJR 143: 63–68.
Gratz K, Creutzig H, Brölsch C, Neuhaus P, Müller S, Pichlmayr R, Hundeshagen H (1984a) ‘Differentialdiagnostik von Lebertumoren mit nuklearmedizinischen Verfahren.’ Radioakt Isotope Klinik Forschung 16: 297–302.
Birnbaum B, Weinreb J, Megibow A, Sanger J, Lubat E, Kanamuller H, Noz M, Bosniak M (1990) ‘Definitive diagnosis of hepatic hemangiomas: MR imaging versus 99mTc-labeled red blood cell SPECT.’ Radiology 176: 95–101.
Gratz K, Creutzig H, Brölsch C, Neuhaus P, Majewski A, Pichlmayr R, Hundeshagen H (1984b) ‘Choleszintigraphie zum Nachweis der focal-nodulären Hyperplasie (FNH) der Leber?’ Chirurg 55: 448–451.
Gratz K, Schober O, Huhle T, Hundeshagen H (1988) ‘99m Tc-HMPAO uptake by liver tumours.’ Nucl Med 27: 117.
Cannon J, Long R, Berens S, Caplan G (1980) ‘Uptake of 99mTc-PIPIDA in pulmonary metastases from a hepatoma.’ Clin Nucl Med 5: 22.
Calvet X, Pons F, Bruix J, Bru C, Lomena F, Herranz R, Brugera M, Faus R, Rodes J (1988) ‘99mTc DISIDA hepatobiliary agent in diagnosis of hepatocellular carcinoma: Relationship between detectability and tumor differentiation.’ J Nucl Med 29: 1916–1920.
Kotzerke J, Krischek O, Schwarzrock R, Wiese H, Ringe B, Hundeshagen H (1989) ‘Focal nodular hyperplasia (FNH) and hepatocellular carcinoma (HCC) - How reliable is their differentiation by cholescintigraphy?’ Eur J Nucl Med 15/8: 531.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1991 Springer Science+Business Media Dordrecht
About this chapter
Cite this chapter
Gratz, K.F., Schober, O., Ringe, B. (1991). Differential diagnosis of liver tumors. In: Biersack, J., Cox, H. (eds) Nuclear Medicine in Gastroenterology. Developments in Nuclear Medicine, vol 18. Springer, Dordrecht. https://doi.org/10.1007/978-94-011-3316-6_7
Download citation
DOI: https://doi.org/10.1007/978-94-011-3316-6_7
Publisher Name: Springer, Dordrecht
Print ISBN: 978-94-010-5464-5
Online ISBN: 978-94-011-3316-6
eBook Packages: Springer Book Archive